...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Eligibility for registered accounts in Canada

bfw - It now seems that after much discussion on this board that you should ask your broker how he came to that conclusion, as pretty much everything covered suggests otherwise.

tada

Share
New Message
Please login to post a reply